Neuren Pharmaceuticals Limited (NURPF)
OTCMKTS · Delayed Price · Currency is USD
9.86
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Neuren Pharmaceuticals Market Cap
Neuren Pharmaceuticals has a market cap or net worth of $1.22 billion as of February 12, 2026. Its market cap has increased by 7.17% in one year.
Market Cap
1.22B
Enterprise Value
1.01B
Revenue
143.49M
Ranking
n/a
PE Ratio
12.52
Stock Price
$9.86
Market Cap Chart
Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 16.12M to 1.22B, an increase of 7,488.32%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.21B | -22.99% |
| Dec 31, 2025 | 1.57B | 60.00% |
| Dec 31, 2024 | 982.52M | -54.64% |
| Dec 29, 2023 | 2.17B | 218.26% |
| Dec 30, 2022 | 680.64M | 97.12% |
| Dec 31, 2021 | 345.30M | 203.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 399.44M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| Vaxart | 141.56M |
| HST Global | 139.70M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 76.77M |
| VitaSpring Biomedical | 51.78M |